Skip to content

Comparison the effect of serum therapy(Ringer,D/S&HES) before spinal anesthesia in elective cesarean section on patients' hemodynamic

Comparison the effect of serum therapy(Ringer,D/S&HES) before spinal anesthesia in elective cesarean section on patients' hemodynamic

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016110730770N1
Enrollment
90
Registered
2017-03-18
Start date
2017-01-19
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Effects of intravenous therapy with D/S’ringer or hydroxi ethyl starch in spinal anesthesia for elective cesarean section on patient’s hemodynamic.

Interventions

Intervention 1: Random, double-blind study designed and After approval by the university ethics committee and recorded in clinical studies in the Iranian system Refer to all pregnant women for electiv
space L3-L4 or L4-L5 using 12/5 mg of bupivacaine 0/5% plus 25 micrograms fentanyl with needle number Gage24 or 25 Gage (needle type is Quincke) under spinal anesthesia by a person qualified or projec
Random, double-blind study designed and After approval by the university ethics committee and recorded in clinical studies in the Iranian system Refer to all pregnant women for elective cesarean secti
The first intervention: an injection of 10 cc of Dexteros-salin serum per kg of body weight before spinal anesthesia (only once) for 15 minutes. Then measure the blood pressure numbers mean arterial b
Second intervention: an injection of 10 cc of Ringer per kg of body weight before spinal anesthesia (only once) for 15 minutes. Then measure the blood pressure numbers mean arterial blood pressure and
Third intervention:an injection of 10 cc of Hydroxi ethil estarch 6% per kg of body weight before spinal anesthesia (only once) for 15 minutes. Then measure the blood pressure numbers mean arterial bl

Sponsors

Vice chancello forresearch, Zahedan university of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Twenty to forty years with normal pregnancy? with ASA class 1 and 2? with a height of 160-180 cm Exclusion criteria: neuromuscular disorders? and neurological diseases? heart disease? high blood pressure? diabetes? organ failure? drug abuse? coagulation disorders? BMI more than 30 before pregnancy" and pre-eclampsia or eclampsia.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Saturation Pressure of arterial oxygen. Timepoint: Every 10 minutes to two hours. Method of measurement: Is performed by anesthesia machine.;Blood pressure, heart rate-MAP-spo2. Timepoint: Every 10 minutes to two hours. Method of measurement: All is done by anesthesia machine.;Heart rate. Timepoint: Every 10 minutes to two hours. Method of measurement: Is performed by anesthesia machine.;Mean arterial pressure. Timepoint: Every 10 minutes to two hours. Method of measurement: Is performed by anesthesia machine.

Secondary

MeasureTime frame
No variable. Timepoint: does not have. Method of measurement: does not have.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDR. Birami. Faranak

Zahedan university of Medical sciences

public@zaums.ac.ir+98 543329571522

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026